Brain Case is a high-tech enterprise focusing on tool viral vector research and translational medicine research. In the past ten years, with the mission of uncovering the “black box of the brain”, it has been committed to the development and application strategies of viral vectors, tracing virus toolkit vectors (RV, PRV, HSV, VSV, CAV, etc.) in neural circuits. ), research on recombinant adeno-associated virus (rAAV) vectors for disease gene therapy, and oncolytic viruses for tumor immunotherapy. It has accumulated rich experience and developed industry-leading preparation systems.

Brain Case currently has a R&D and technical team of more than 70 people, with a master’s and doctoral graduate rate exceeding 45%. It has more than 20 independent intellectual property rights and has built a full-process GMP production and experimental platform in Shenzhen and Wuhan. The company carries out basic scientific research and drug research and development services based on neural circuit research and viral vector technology.

“Serve medical care with a rigorous attitude, observe the world with a scientific perspective.” Brain Case is determined to break through the boundaries of innovation and jointly create human health, and the future is promising!

Media

---